255 related articles for article (PubMed ID: 22718818)
41. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
[TBL] [Abstract][Full Text] [Related]
42. Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.
Liu J; Zhang E; Ma Z; Wu W; Kosinska A; Zhang X; Möller I; Seiz P; Glebe D; Wang B; Yang D; Lu M; Roggendorf M
PLoS Pathog; 2014 Jan; 10(1):e1003856. PubMed ID: 24391505
[TBL] [Abstract][Full Text] [Related]
43. Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects.
Zhang E; Kosinska AD; Ma Z; Dietze KK; Xu Y; Meng Z; Zhang X; Wang J; Wang B; Dittmer U; Roggendorf M; Yang D; Lu M
Virology; 2015 Jan; 475():56-65. PubMed ID: 25462346
[TBL] [Abstract][Full Text] [Related]
44. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen.
Haq K; Jia Y; Elahi SM; MacLean S; Akache B; Gurnani K; Chattopadhyay A; Nazemi-Moghaddam N; Gilbert R; McCluskie MJ; Weeratna RD
Vaccine; 2019 Nov; 37(47):7029-7040. PubMed ID: 31506193
[TBL] [Abstract][Full Text] [Related]
46. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.
Frank I; Budde C; Fiedler M; Dahmen U; Viazov S; Lu M; Dittmer U; Roggendorf M
J Virol; 2007 Jul; 81(13):7156-63. PubMed ID: 17459928
[TBL] [Abstract][Full Text] [Related]
47. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
Mancini M; Hadchouel M; Tiollais P; Michel ML
J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
[TBL] [Abstract][Full Text] [Related]
48. Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Whitacre DC; Peters CJ; Sureau C; Nio K; Li F; Su L; Jones JE; Isogawa M; Sallberg M; Frelin L; Peterson DL; Milich DR
Hum Vaccin Immunother; 2020; 16(2):251-268. PubMed ID: 31809638
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
Roggendorf M; Schulte I; Xu Y; Lu M
J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
[TBL] [Abstract][Full Text] [Related]
50. Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.
Cote PJ; Butler SD; George AL; Fairman J; Gerin JL; Tennant BC; Menne S
J Med Virol; 2009 Oct; 81(10):1760-72. PubMed ID: 19697409
[TBL] [Abstract][Full Text] [Related]
51. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
52. Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV.
Morrey JD; Motter NE; Chang S; Fairman J
Antiviral Res; 2011 Jun; 90(3):227-30. PubMed ID: 21545812
[TBL] [Abstract][Full Text] [Related]
53. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
Chuai X; Xie B; Chen H; Tan X; Wang W; Huang B; Deng Y; Li W; Tan W
Vaccine; 2018 Jun; 36(26):3740-3746. PubMed ID: 29778513
[TBL] [Abstract][Full Text] [Related]
54. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
55. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
Böcher WO; Dekel B; Schwerin W; Geissler M; Hoffmann S; Rohwer A; Arditti F; Cooper A; Bernhard H; Berrebi A; Rose-John S; Shaul Y; Galle PR; Löhr HF; Reisner Y
Eur J Immunol; 2001 Jul; 31(7):2071-9. PubMed ID: 11449360
[TBL] [Abstract][Full Text] [Related]
56. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
57. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.
Obeng-Adjei N; Hutnick NA; Yan J; Chu JS; Myles DJ; Morrow MP; Sardesai NY; Weiner DB
Cancer Gene Ther; 2013 Dec; 20(12):652-62. PubMed ID: 24310062
[TBL] [Abstract][Full Text] [Related]
58. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
[TBL] [Abstract][Full Text] [Related]
59. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
60. Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination.
Krieger J; Stifter K; Riedl P; Schirmbeck R
Sci Rep; 2018 Oct; 8(1):14660. PubMed ID: 30279478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
